Highlights From the 2013 Gastrointestinal Cancers Symposium

View
22
Download
1
Category

Documents

Tags:

vs gemcitabine
ramicirumabregard trial
adjuvant therapy
longerterm adjuvant
better efficacy
standard of care

Preview:

DESCRIPTION

Highlights From the 2013 Gastrointestinal Cancers Symposium. Highlights of the 2013 Genitourinary Cancers Meeting. Phase 3 Metastatic Pancreatic Adenocarcimona (MPACT) Trial. Pancreatic Cancer. Comparison of Phase 2/Phase 3 Data. - PowerPoint PPT Presentation

Citation preview

Highlights From the 2013 Gastrointestinal Cancers Symposium

Documents

2012 GU Cancers Symposium

Genomics Applications in Gastrointestinal Cancers: from

Targeting the immune milieu in gastrointestinal cancers · 2 days ago · REVIEW Targeting the immune milieu in gastrointestinal cancers Fiona Turkes1 • Justin Mencel1 • Naureen

Upper GI Cancers: Risk Stratification and Treatment Selection David H. Ilson, MD, PhD Gastrointestinal Oncology Service Memorial Sloan-Kettering Cancer

Second Oklahoma Prostate and Urologic Cancers …...09.24.16 Second Oklahoma Prostate and Urologic Cancers Symposium 6:30 am - 3 pm / Saturday, Sept. 24, 2016 SAMIS EDUCATION CENTER,

Upper gastrointestinal cancers Dr Sue Darby Consultant Medical Oncologist Weston Park Hospital Sheffield

Updates and news from the Gastrointestinal Cancers

RIP140 and LCoR expression in gastrointestinal cancers

Innate Immunity in Gastrointestinal Disorders: Basic and ...€¦ · Preliminary Program Falk Symposium 181 Innate Immunity in Gastrointestinal Disorders: Basic and Therapeutic Concepts

2019 ASCO Genitourinary Cancers Symposium · 2019-02-15 · 2019 ASCO-GU Incidence of Urothelial Cancer • Urothelial cancers encompass carcinomas of the bladder, ureters, and renal

2011 ASCO Genitourinary Cancers Symposium 17-19 February 2011, Orlando

Report from the ASCO Gastrointestinal Cancers Symposium...oe VOL. 15, NO. 2, may 2016 23 Report from the ASCO Gastrointestinal Cancers Symposium GI-tract neuroendocrine tumours EVErOLimus

Gastric and Esophageal Cancers: ASCO 2013 Poster Discussion Section David H. Ilson, MD, PhD Gastrointestinal Oncology Service Memorial Sloan-Kettering

ORGANOIDS Patient-derived organoids model treatment response … · ORGANOIDS Patient-derived organoids model treatment response of metastatic gastrointestinal cancers Georgios Vlachogiannis,

INHERITED GASTROINTESTINAL CANCERS AND ... GI Cancers...inherited cancer syndromes and integrate familial cancer risk assessment, genetic testing approaches, assessment of actionable

ReviewArticle Immunotherapy in Gastrointestinal Cancersdownloads.hindawi.com/journals/bmri/2017/4346576.pdfReviewArticle Immunotherapy in Gastrointestinal Cancers LetiziaProcaccio,1,2

Gastrointestinal cancers (Pt. I.) · PDF fileNyelőcsőrák – etiológia, tünetek • Hajlamosító tényezők: –GERD - Barrett metaplasia-dysplasia –dohányzás, alkohol, forró

ASCO - Gastrointestinal Cancers Symposium Orlando (FL), 25-27 January 2008 First-line Irinotecan, Oxaliplatin and Infusional 5FU/LV (FOLFOXIRI) in combination

Update in Upper Gastrointestinal Cancers

Updates in Gastrointestinal (GI) Cancers · 2019-11-07 · GI Cancers –An Urgent Need •Consists of cancers of the esophagus, stomach, liver, pancreas, small intestine, colon,